This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.36 delivery order covers the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a pharmaceutical product.
The contract has an ultimate completion date of December 17, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order falls under that larger IDC contract.
Generated 3/17/25, 9:50 AM